HKSE - Delayed Quote HKD
GENSCRIPT BIO (1548.HK)
11.060
+0.020
+(0.18%)
As of 2:54:52 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
75,647
75,647
-286,911
-120,292
-136,790
Investing Cash Flow
-1,456,363
-1,456,363
-357,728
-443,296
-212,548
Financing Cash Flow
66,519
66,519
1,068,260
419,317
902,141
End Cash Position
131,990
131,990
1,446,403
1,023,999
1,180,971
Capital Expenditure
-147,920
-147,920
-157,713
-203,572
-135,689
Issuance of Capital Stock
13,486
13,486
1,030,168
423,307
951,229
Issuance of Debt
102,606
102,606
74,388
33,062
26,041
Repayment of Debt
-58,166
-58,166
-24,606
-463
-71,216
Free Cash Flow
-72,273
-72,273
-444,624
-323,864
-272,479
12/31/2021 - 12/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2157.HK Lepu Biopharma Co., Ltd.
4.320
+3.10%
1530.HK 3SBIO
13.340
+4.22%
2563.HK Beijing Biostar Pharms Co Ltd
4.410
-17.42%
6622.HK Zhaoke Ophthalmology Limited
1.650
-0.60%
2410.HK TYK Medicines, Inc
26.850
-2.19%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
303.400
+1.61%
688235.SS BeiGene, Ltd.
243.48
-1.06%
1952.HK Everest Medicines Limited
46.300
-6.84%
XTLB XTL Biopharmaceuticals Ltd.
1.2150
-7.25%
9688.HK Zai Lab Limited
25.700
-1.15%